Association of the K153R polymorphism in the myostatin gene and extreme longevity

Age

Volumn 35, Issue 6, 2013, Pages 2445-2454

  Garatachea, Nuria ^a   Pinós, Tomàs ^b,c   Cámara, Yolanda ^b,c   Rodríguez Romo, Gabriel ^d   Emanuele, Enzo ^e   Ricevuti, Giovanni ^e   Venturini, Letizia ^e   Santos Lozano, Alejandro ^a   Santiago Dorrego, Catalina ^f   Fiuza Luces, Carmen ^f   Yvert, Thomas ^f   Andreu, Antoni L ^b,c   Lucia, Alejandro ^f  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Centenarians; Genetics; MSTN

Indexed keywords

ARGININE; LYSINE; MYOSTATIN;

AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LONGEVITY; MALE; MSTN GENE; SEX DIFFERENCE; VERY ELDERLY;

AGED, 80 AND OVER; ALLELES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGEVITY; MALE; MYOSTATIN; PHENOTYPE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SARCOPENIA;

EID: 84892510232     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-013-9513-3     Document Type: Article

References (65)

1. Amirouche A, Durieux AC, Banzet S, Koulmann N, Bonnefoy R, Mouret C, Bigard X, Peinnequin A, Freyssenet D (2009) Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150(1):286-294. doi:10.1210/en.2008-0959
2. Baumann AP, Ibebunjo C, Grasser WA, Paralkar VM (2003) Myostatin expression in age and denervation-induced skeletal muscle atrophy. J Musculoskelet Neuronal Interact 3(1):8-16
3. Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA (2010) Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun 391 (3):1548-1554. doi:10.1016/j.bbrc.2009.12.123
4. Bjedov I, Partridge L (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. Biochem Soc Trans 39(2):460-465. doi:10.1042/BST0390460
5. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420(6914):418-421. doi:10.1038/nature01154
6. Carlson CJ, Booth FW, Gordon SE (1999) Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 277(2 Pt 2):R601-606
7. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS (2007) Replicating genotype-phenotype associations. Nature 447(7145):655-660. doi:10.1038/447655a
8. Christensen K, McGue M, Petersen I, Jeune B, Vaupel JW (2008) Exceptional longevity does not result in excessive levels of disability. Proc Natl Acad Sci U S A 105 (36):13274-13279. doi:10.1073/pnas.0804931105
9. Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL Index: a reliability study. Int Disabil Stud 10(2):61-63
10. Constantin D, McCullough J, Mahajan RP, Greenhaff PL (2011) Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589(Pt 15):3883-3895. doi:10.1113/jphysiol.2011.206193
11. Corsi AM, Ferrucci L, Gozzini A, Tanini A, Brandi ML (2002) Myostatin polymorphisms and age-related sarcopenia in the Italian population. J Am Geriatr Soc 50(8):1463
12. Cybulski N, Hall MN (2009) TOR complex 2: a signaling pathway of its own. Trends Biochem Sci 34(12):620-627.doi:10.1016/j.tibs.2009.09.004
13. Dasarathy S, Dodig M, Muc SM, Kalhan SC, McCullough AJ (2004) Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. Am J Physiol Gastrointest Liver Physiol 287(6):G1124-1130.doi:10.1152/ajpgi.00202.2004
14. Emanuele E, Fontana JM, Minoretti P, Geroldi D (2010) Preliminary evidence of a genetic association between chromosome 9p21.3 and human longevity. Rejuvenation research 13(1):23-26. doi:10.1089/rej.2009.0970
15. Fenton TR, Gout IT (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. Int J Biochem Cell Biol 43 (1):47-59. doi:10.1016/j. biocel.2010.09.018
16. Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM,Hurley BF (1999) Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 62(2):203-207.doi:10.1006/geno. 1999.5984
17. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
18. Fontana L, Partridge L, Longo VD (2010) Extending healthy life span - from yeast to humans. Science 328(5976):321-326. doi:10.1126/science.1172539
19. Garatachea N, Lucía A (2013) Genes and the ageing muscle: a review on genetic association studies. Age (Dordr) 35 (1):207-233. doi:10.1007/s11357-011-9327-0
20. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S (1998) Organization of the human myostatin gene and expression in healthy men and HIVinfected men with muscle wasting. Proc Natl Acad Sci U S A 95(25):14938-14943
21. Gonzalez-Freire M, Rodriguez-Romo G, Santiago C,Bustamante-Ara N, Yvert T, Gomez-Gallego F, Serra Rexach JA, Ruiz JR, Lucia A (2010) The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan. Age 32(3):405-409. doi:10.1007/s11357-010-9139-7
22. Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, Georges M (1997) A deletion in the bovine myostatin gene causes the doublemuscled phenotype in cattle. Nat Genet 17(1):71-74.doi:10.1038/ng0997-71
23. Huygens W, Thomis MA, Peeters MW, Aerssens J, Janssen R, Vlietinck RF, Beunen G (2004) Linkage of myostatin pathway genes with knee strength in humans. Physiol Genom 17(3):264-270. doi:10.1152/physiolgenomics.00224.2003
24. Jiang MS, Liang LF,Wang S, Ratovitski T, Holmstrom J, Barker C, Stotish R (2004) Characterization and identification of the inhibitory domain of GDF-8 propeptide. Biochem Biophys Res Commun 315(3):525-531. doi:10.1016/j.bbrc.2004. 01.085
25. Kawada S, Tachi C, Ishii N (2001) Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading. J Muscle Res Cell Motil 22(8):627-633
26. Kenyon CJ (2010) The genetics of ageing. Nature 464 (7288):504-512. doi:10.1038/nature08980
27. Kostek MA, Angelopoulos TJ, Clarkson PM, Gordon PM, Moyna NM, Visich PS, Zoeller RF, Price TB, Seip RL, Thompson PD, Devaney JM, Gordish-Dressman H, Hoffman EP, Pescatello LS (2009) Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc 41(5):1063-1071.doi:10.1249/MSS.0b013e3181930337
28. Krivickas LS, Walsh R, Amato AA (2009) Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve 39(1):3-9. doi:10.1002/mus.21200
29. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem277(51):49831-49840. doi:10.1074/jbc.M204291200
30. Lawlor MW, Read BP, Edelstein R, Yang N, Pierson CR, Stein MJ, Wermer-Colan A, Buj-Bello A, Lachey JL, Seehra JS, Beggs AH (2011) Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. Am J Pathol 178(2):784-793. doi:10.1016/j.ajpath. 2010.10.035
31. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98 (16):9306-9311. doi:10.1073/pnas.151270098
32. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattlebaum E, Stotish RL, Wolfman NM (2005) Regulation of muscle growth by multiple ligands signaling through activin type 2 receptors. Proc Natl Acad Sci U S A 102(50):18117-18122.doi:10.1073/pnas. 0505996102
33. Lipina C, Kendall H, McPherron AC, Taylor PM, Hundal HS (2010) Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Lett 584(11):2403-2408. doi:10.1016/j.febslet.2010.04.039
34. Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, Sun LQ (2008) Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Ther 15(3):155-160. doi:10.1038/sj.gt.3303016
35. Mahoney FI, Barthel DW (1965) Functional Evaluation: the Barthel Index. Md State Med J 14:61-65
36. Martin GM, Bergman A, Barzilai N (2007) Genetic determinants of human health span and life span: progress and new opportunities. PLoS Genet 3(7):e125. doi:10.1371/journal.pgen.0030125
37. McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, Smith H, Sharma M, Kambadur R (2006) Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 209(2):501-514. doi:10.1002/jcp.20757
38. McPherron AC, Lee SJ (1997) Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 94(23):12457-12461
39. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamilymember. Nature 387(6628):83-90. doi:10.1038/387083a0
40. Metter EJ, Talbot LA, Schrager M, Conwit RA (2004) Armcranking muscle power and arm isometric muscle strength are independent predictors of all-cause mortality in men. J Appl Physiol 96(2):814-821. doi:10.1152/japplphysiol. 00370.2003
41. Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, Reino M, Geroldi D (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 391(3):147-149. doi:10.1016/j.neulet.2005.08.047
42. Morissette MR, Stricker JC, Rosenberg MA, Buranasombati C, Levitan EB, Mittleman MA, Rosenzweig A (2009) Effects of myostatin deletion in aging mice. Aging cell 8(5):573-583. doi:10.1111/j.1474-9726.2009.00508.x
43. Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, Kumar R, Sako D, Grinberg A, Wong V, Colantuoni E, Seehra JS, Wagner KR (2009) A soluble activin type 2B receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 217(2):258-268. doi:10.1016/j. expneurol.2009.02.017
44. Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, Ostrander EA (2007) A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS genetics 3(5):e79. doi:10.1371/journal.pgen.0030079
45. Murphy KT, Ryall JG, Snell SM, Nair L, Koopman R, Krasney PA, Ibebunjo C, Holden KS, Loria PM, Salatto CT, Lynch GS (2010) Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. Am J Pathol 176(5):2425-2434. doi:10.2353/ajpath.2010.090932
46. Neufeld TP (2010) TOR-dependent control of autophagy: biting the hand that feeds. Curr Opin Cell Biol 22(2):157-168.doi:10.1016/j.ceb.2009.11.005
47. Qiao C, Li J, Zheng H, Bogan J, Yuan Z, Zhang C, Bogan D, Kornegay J, Xiao X (2009) Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther 20(1):1-10.doi:10.1089/hum.2008.135
48. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90(4):1383-1435.doi:10.1152/physrev. 00030.2009
49. Rios R, Fernandez-Nocelos S, Carneiro I, Arce VM, Devesa J (2004) Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 145(6):2795-2803.doi:10.1210/en.2003-1166
50. Rose FF Jr, Mattis VB, Rindt H, Lorson CL (2009) Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet 18 (6):997-1005. doi:10.1093/hmg/ddn426
51. Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjostrom M, Blair SN (2008) Association between muscular strength and mortality in men: prospective cohort study. BMJ 337: a439. doi:10.1136/bmj.a439
52. Sakuma K, Yamaguchi A (2012) Sarcopenia and age-related endocrine function. Int J Endocrinol 2012:127362. doi:10.1155/2012/127362
53. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, Sandri M (2009) Smad2 and 3 transcription factors control muscle mass in adulthood. Am J PhysiolCell Physiol 296(6):C1248-1257. doi:10.1152/ajpcell.00104.2009
54. Saunders MA, Good JM, Lawrence EC, Ferrell RE, Li WH, Nachman MW (2006) Human adaptive evolution at myostatin (GDF8), a regulator of muscle growth. Am J Hum Genet 79(6):1089-1097. doi:10.1086/509707
55. Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40(2):310-322. doi:10.1016/j.molcel.2010.09.026
56. Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M (2006) Prolonged absence of myostatin reduces sarcopenia. J Cell Physiol 209(3):866-873. doi:10.1002/jcp.20778
57. Sparks CA, Guertin DA (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29(26):3733-3744. doi:10.1038/onc.2010. 139
58. Swan M (2011) Meeting report: American Aging Association 40th Annual Meeting, Raleigh, North Carolina, June 3-6,2011. Rejuvenation research 14(4):449-455. doi:10.1089/rej.2011.1216
59. Terry DF, Sebastiani P, Andersen SL, Perls TT (2008) Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 168(3):277-283. doi:10.1001/archinternmed.2007.75
60. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296(6):C1258-1270. doi:10.1152/ajpcell.00105.2009
61. Tsuchida K (2008) Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice. Acta Myol 27:14-18
62. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR (2008) A phase 1/2trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63(5):561-571. doi:10.1002/ana. 21338
63. Welle S, Bhatt K, Shah B, Thornton C (2002) Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men. ExpGerontol 37(6):833-839
64. Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF (2002) Serum myostatinimmunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6(5):343-348
65. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J (2007) Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem 282 (35):25852-25863. doi:10.1074/jbc.M704146200